ACE and hydrops fetalis: It stems from the fact that the treatment of HF is based on the use of angiotensin-converting enzyme inhibitors and beta-adrenergic receptor blockers, which can significantly modulate plasma concentrations of these hormones, thereby interfering with their interpretation and reducing their predictive value in risk stratification [135].